NDUFA11

Across TCGA pan-cancer cohorts, NDUFA11 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NDUFA11 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher NDUFA11 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated NDUFA11 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.

UCEC, CCRCC, and OV are the cancer types where NDUFA11 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	1.000	0.865	.020	10	view →
CCRCC	OS	Median	All	0.994	0.884	.020	9	view →
OV	DFS	Tertile	All	1.000	0.834	.033	4	view →
LSCC	DFS	Median	II,III,IV	0.822	0.533	.009	4	view →
LUAD	DFS	Quartile	All	0.540	1.000	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NDUFA11–UCEC (OS)

Open the UCEC breakdown →